Adaptive Lacrimal Systems for Niche Environments

Publication ID: 24-11857461_0004_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Adaptive Lacrimal Systems for Niche Environments,” Published Technical Disclosure No. 24-11857461_0004_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857461_0004_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,461.

Summary of the Inventive Concept

A lacrimal system device and methods for delivering drugs to the eye, sinuses, and/or periocular tissues in specialized environments, such as high-altitude, disaster relief, high-security, extreme weather conditions, and search and rescue operations.

Background and Problem Solved

The original lacrimal system patent addressed the challenges of ocular and respiratory disease management, but it lacked adaptability for unique operational environments. This inventive concept adapts the lacrimal system for specific, narrow markets, overcoming the limitations of the original patent in these contexts.

Detailed Description of the Inventive Concept

The inventive concept comprises a lacrimal system device with a reservoir balloon and a tube having at least a first lumen and a second lumen. The device is adapted for use in specialized environments, including high-altitude environments, disaster relief settings, high-security environments, extreme weather conditions, and search and rescue operations. The adaptations include features such as low atmospheric pressure resistance, tamper-evidence, freezing temperature resistance, and compact, lightweight designs. The device delivers controlled amounts of medication to the eye, sinuses, and/or periocular tissues, addressing specific needs in these environments.

Novelty and Inventive Step

The inventive concept's novelty lies in its adaptability for niche environments, which is not addressed in the original patent. The inventive step is the incorporation of environment-specific features that enable the lacrimal system to operate effectively in these unique contexts.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include variations in the reservoir balloon material, tube geometry, and flow-limiting plug design to accommodate different environmental conditions. Additionally, the device could be integrated with other medical devices or sensors to enhance its functionality.

Potential Commercial Applications and Market

The inventive concept has potential commercial applications in the medical device industry, particularly in the areas of ophthalmology, emergency response, and environmental medicine. The target markets include high-altitude regions, disaster relief organizations, high-security facilities, and search and rescue teams.

CPC Classifications

SectionClassGroup
A A61 A61F9/00772
A A61 A61F9/0017
A A61 A61M37/00
A A61 A61M31/002

Field of Art

Medical device design for ophthalmic and drug delivery systems, specifically focused on lacrimal system interventions with expertise in biomedical engineering, materials science, and controlled drug delivery mechanisms

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device designer with advanced degree, working knowledge of fluid dynamics, material properties, drug delivery technologies, and environmental adaptation strategies for medical devices

Obviousness Rationale

A PHOSITA would recognize that adapting the fundamental lacrimal drug delivery system to specialized environmental conditions represents a predictable variation using known engineering design principles. The core mechanism of drug delivery remains consistent with the source patent, while environmental adaptations represent standard design modifications within medical device engineering. The variations demonstrate routine problem-solving by applying known material science and device design techniques to extend the original invention's utility.

Obvious Combinations & Variations

Source Patent Element
Reservoir balloon with exit port for fluid enclosure and controlled drug delivery
PTD Variation
Modifying reservoir balloon materials to withstand low atmospheric pressure or freezing temperatures
Obviousness Reasoning
Material selection for environmental resistance is a predictable design choice using known polymer engineering techniques, representing a standard engineering optimization process
Source Patent Element
Tube with multiple lumens for drug delivery
PTD Variation
Adapting tube geometry for compact and lightweight configurations in search and rescue environments
Obviousness Reasoning
Miniaturization and geometric optimization are well-established design techniques in medical device engineering, representing a known approach to context-specific device adaptation
Source Patent Element
Drug delivery system targeting periocular tissues
PTD Variation
Implementing tamper-evident features for high-security environments
Obviousness Reasoning
Integrating security mechanisms into medical devices is a known technique, representing a straightforward application of existing security engineering principles
Source Patent Element
Active agent delivery mechanism
PTD Variation
Tailoring medication release for specific environmental conditions like disaster relief settings
Obviousness Reasoning
Modifying drug delivery parameters based on environmental constraints represents a predictable engineering optimization using known controlled-release technologies
Source Patent Element
Lacrimal system device with flow control mechanisms
PTD Variation
Integrating environmental adaptation features into existing drug delivery architecture
Obviousness Reasoning
Extending device functionality through environmental adaptation represents a standard engineering approach of incremental innovation using known design principles
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857461, a person having ordinary skill in the art would find the variations disclosed in the Published Technical Disclosure to represent obvious extensions of the prior art, wherein the fundamental drug delivery mechanism remains substantially unchanged while environmental adaptations represent routine engineering design choices that would be apparent to a skilled practitioner in the field of medical device design.

Original Patent Information

Patent NumberUS 11,857,461
TitleLacrimal system for drug delivery
Assignee(s)The Regents of the University of Colorado, a body corporate